| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000Ka 4500 |
| 001 |
in00001841237 |
| 005 |
20211202201802.0 |
| 008 |
040504s2000 mdu s f000 0 eng d |
| 035 |
|
|
|a (OCoLC)ocm55074311
|
| 040 |
|
|
|a GPO
|c GPO
|d MvI
|d UtOrBLW
|
| 049 |
|
|
|a WWW
|
| 074 |
|
|
|a 0491-B-31 (online)
|
| 086 |
0 |
|
|a HE 20.6524:21/SUM.
|
| 245 |
0 |
0 |
|a Milk thistle :
|b effects on liver disease and cirrhosis and clinical adverse effects.
|
| 264 |
|
1 |
|a [Rockville, Md.] :
|b [Agency for Healthcare Research and Quality],
|c [2000]
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a unspecified
|b zu
|2 rdacarrier
|
| 490 |
1 |
|
|a AHRQ publication ;
|v no. 01-E 024
|
| 490 |
1 |
|
|a Evidence report/technology assessment. Summary ;
|v no. 21
|
| 538 |
|
|
|a Mode of access: Internet from the AHRQ web site. Address as of 5/4/04: http://www.ahrq.gov/clinic/epcsums/milktsum.htm; current access available via PURL.
|
| 500 |
|
|
|a Title from title screen (viewed on May 4, 2004).
|
| 500 |
|
|
|a Electronic resource.
|
| 650 |
|
0 |
|a Milk thistle
|x Therapeutic use.
|
| 650 |
|
0 |
|a Milk thistle
|x Toxicology.
|
| 650 |
|
0 |
|a Liver
|x Diseases
|x Treatment.
|
| 776 |
1 |
|
|t Milk thistle
|h 3 p.
|w (OCoLC)45610879
|
| 710 |
1 |
|
|a United States.
|b Agency for Healthcare Research and Quality.
|
| 830 |
|
0 |
|a AHRQ publication ;
|v no. 01-E 024.
|
| 830 |
|
0 |
|a Evidence report/technology assessment.
|p Summary ;
|v no. 21.
|
| 856 |
4 |
0 |
|u https://purl.fdlp.gov/GPO/LPS48477
|t 0
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s 45dbdc38-2373-3340-b650-35fbbca9e4b1
|i 8da244f2-c6a3-3e7a-8bc6-cd9ab1ce529e
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|d Available Online
|t 0
|e HE 20.6524:21/SUM.
|h Superintendent of Documents classification
|
| 998 |
f |
f |
|a HE 20.6524:21/SUM.
|t 0
|l Available Online
|